Patient decision aids (P�DAs)	control	decision satisfaction, decision regret, cancer�related worry (Assessment of Survivor Concerns), mood, and trust in the treating physician, subscale measures of cancer worry or health worry of the Assessment of Survivor Concerns questionnairerespective anxiety, worry , interest, or depression measures of the Patient Health Questionnaire for Depression and Anxiety 4 mood screening questionnaire.	18796	19582	There were no significant differences between the P‐DA and no–P‐DA groups in the following outcomes: decision satisfaction (P = .142), decision regret (P = .199), cancer‐related worry (Assessment of Survivor Concerns; P = .645), mood (P = .211), and trust in the treating physician (P = .764; Table 2). Furthermore, there was no significant difference between groups for any of the respective subscale measures of cancer worry (P = .718) or health worry (0.191) of the Assessment of Survivor Concerns questionnaire. Also, there was no significant difference between groups for any of the respective anxiety (P = .107), worry (P = .251), interest (P = .912), or depression measures (P = .286) of the Patient Health Questionnaire for Depression and Anxiety 4 mood screening questionnaire.
Patient decision aids (P�DAs)	control	informed about the treatment choice, aware of options, knowledgeable about treatment benefits, and knowledgeable about treatment risks/side effects 	1322	1611	P‐DA users perceived themselves to be significantly more 1) informed about the treatment choice (P = .008), 2) aware of options (P = .009), 3) knowledgeable about treatment benefits (P = .020), and 4) knowledgeable about treatment risks/side effects (P = .001) in comparison with controls.
